Public health & disease

From disease eradication efforts to advances in vaccination and maternal health, this archive tracks real progress in public health. Stories here focus on what’s working — policies, interventions, and research that are improving and extending lives around the world.

Eye exam, for article on trachoma elimination

Australia becomes 30th country to eliminate trachoma as a public health concern

By / / Good News For Humankind

Trachoma has officially been eliminated as a public health concern in Australia, making it the 30th country to defeat the world’s leading infectious cause of blindness. The win took nineteen years of patient work in Aboriginal and Torres Strait Islander communities, where the disease quietly persisted long after vanishing from cities. What made the difference wasn’t a miracle drug — it was Aboriginal Community Controlled Health Organizations leading the response, paired with better housing, cleaner water, and treatment designed around local realities rather than imposed from outside. Health Minister Mark Butler said the lessons will shape how Australia tackles other preventable illnesses in remote regions. For the 125 million people still living in trachoma-endemic areas worldwide, Australia’s playbook offers something rare: proof that community-led care actually works.

Two sets of hand holding newborn baby, for article on Coartem Baby malaria treatment

W.H.O. approves world’s first malaria treatment for newborn babies

By / / Good News For Humankind

Newborn babies with malaria finally have a medicine made just for them. Coartem Baby, a cherry-flavored tablet that dissolves into breast milk or water, just earned World Health Organization prequalification — a green light that opens the door to public health systems across sub-Saharan Africa. For decades, doctors had to guess at doses using drugs built for older children, even as research showed infants were getting infected too. Ghana has already begun rolling it out, and Novartis has committed to what it calls “largely not-for-profit pricing” in malaria-endemic regions. Alongside new vaccines and better bed nets, it’s a quiet but meaningful sign that the fight against malaria — which still kills hundreds of thousands of children a year — is reaching the patients it had long overlooked.

Holding a nasal spray, for article on prehospital stroke nasal spray

Hong Kong researchers develop world-first nasal spray for stroke, cutting damage 80%

By / / Good News For Humankind

A nasal spray for stroke, developed at the University of Hong Kong, cut brain damage by more than 80% when given within 30 minutes of an ischemic stroke in preclinical studies. The idea is beautifully simple: tiny particles travel from the nose directly along nerve pathways to the brain, sidestepping the blood-brain barrier that derails most neurological drugs. Designed to be as easy to use as an EpiPen, it could let a bystander start protecting brain cells before the ambulance even arrives. Clinical trials are still years away, but if it holds up, this kind of “protection-first” thinking could reshape emergency care for stroke patients everywhere — especially the 85% who currently never reach treatment in time.

Female protester with megaphone, for article on rape kit reform

All 50 U.S. states now have rape kit reform laws after 16-year campaign

By / / Good News For Humankind

Rape kit reform just hit a milestone 16 years in the making: with Maine’s new law on May 1, 2026, all 50 states, Washington D.C., and Puerto Rico now have at least one pillar of reform on the books. The campaign began when survivors started writing letters to actress Mariska Hargitay, whose Joyful Heart Foundation later built a research-grounded framework called the Six Pillars — covering mandatory testing, dedicated funding, and a survivor’s right to know what happened to their own kit. Before this wave, a person could endure an hours-long exam and never learn if the evidence was tested. Laws on paper aren’t justice in practice yet, but the distance covered shows what survivor-led advocacy can accomplish when it refuses to quit.

Supplement capsule, for article on vitamin D breast cancer study

Brazilian scientists find that vitamin D boosts breast cancer treatment success by 79%

By / / Good News For Humankind

Vitamin D may give breast cancer chemotherapy a meaningful boost, according to a new randomized trial in Brazil. Among 80 women undergoing chemo before surgery, those taking 2,000 IU of vitamin D daily saw their tumors completely disappear 43% of the time, compared with 24% in the placebo group. Researchers think the nutrient may act as a chemosensitizer, helping cancer cells respond more fully to treatment. The authors are careful to note that a trial this small isn’t the final word, and larger studies are needed before guidelines change. Still, the idea that something as simple, safe, and affordable as vitamin D could improve outcomes for the world’s most commonly diagnosed cancer is genuinely hopeful news worth watching.

Cameroonian child, for article on malaria vaccine rollout

Cameroon’s malaria vaccine cuts child cases 20% in first year

By / / Good News For Humankind

Cameroon’s malaria vaccine rollout delivered something remarkable in its first year: nearly 67,000 fewer malaria cases among children under five across 42 high-burden districts, a 20% drop compared to 2023. The country was one of 13 across Africa to fold the long-awaited vaccine into routine childhood immunization in 2024, part of a coordinated regional push that delivered more than 18 million doses. Among the first to be vaccinated were twins born in January 2024, whose mother says simply that they have never had malaria. After three decades of development and years of pilot studies, a tool once considered out of reach is now protecting children at scale — and the early evidence suggests it is working.

HIV up close, for article on mother-to-child HIV transmission

The Bahamas officially eliminates mother-to-child transmission of HIV

By / / Good News For Humankind

The Bahamas just became the 12th country or territory in the Americas certified by the World Health Organization for eliminating mother-to-child HIV transmission — meaning babies born there now enter the world free of the virus by design, not by luck. The country built this through a quietly powerful idea: every pregnant woman, regardless of nationality or legal status, gets HIV screening at her first prenatal visit and again later in pregnancy, with treatment and follow-up offered free. Reaching that standard across more than 700 scattered islands took years of coordination between nurses, doctors, and public clinics. More than half of all places worldwide to achieve this milestone are now in Latin America and the Caribbean — proof that with universal care and political will, this victory is replicable anywhere.

Scientist filling tubes, for article on reversible male contraception

Cornell researchers achieve first reversible male birth control in mice

By / / Good News For Humankind

Reversible male birth control just cleared a major hurdle: in a new Cornell study, male mice stopped producing sperm entirely after three weeks of treatment, then bounced back to full fertility within six weeks of stopping. The approach skips hormones altogether, targeting a specific window of sperm development in the testis so libido and other traits stay untouched. Even better, the mice went on to father healthy pups who were themselves fertile. The researchers are now testing new molecular targets and hope to launch a company within two years to move toward human trials. If the science holds up across species, it could finally give men a real long-acting option — and ease a contraceptive burden women have shouldered alone for generations.

People holding breast cancer pin, for article on vitamin D breast cancer

Brazilian researchers find vitamin D boosts breast cancer chemo by 79%

By / / Good News For Humankind

Vitamin D may give breast cancer chemotherapy a meaningful boost, according to a new Brazilian trial in which 43% of women taking a daily supplement saw their tumors disappear completely, compared to 24% on a placebo. Researchers at São Paulo State University gave 80 patients a modest 2,000 IU dose alongside their standard pre-surgery chemo — a level safe enough for everyday use and cheap enough for almost anyone. Most women in the study were vitamin D-deficient to begin with, a pattern common in cancer patients worldwide. If larger trials confirm the finding, it points to something rare and hopeful in oncology: a low-cost, low-risk addition that could improve outcomes most for the communities currently facing the steepest deficiency rates and the hardest cancer journeys.

African children smiling, for article on measles vaccination Africa

Nearly 20 million measles deaths averted in Africa since 2000

By / / Good News For Humankind

Measles vaccines in Africa have prevented an estimated 19.5 million deaths since 2000 — roughly 800,000 lives saved every year for nearly a quarter century. A new WHO and Gavi analysis credits steady investment in cold-chain systems, community health workers, and political will, with coverage for the critical second measles dose climbing more than tenfold over that stretch. This year, Cabo Verde, Mauritius, and Seychelles became the first sub-Saharan nations to officially eliminate measles and rubella, a milestone once considered out of reach. The story is a powerful reminder that global health progress, though uneven, compounds quietly over decades — and that protecting children anywhere strengthens the case for protecting them everywhere.